Updates

Our friends at constructiveHEARTS, founded by Peri Phillips in honor of Patrick Chance, have created a line of hand-crafted necklaces that do more than shine—they directly support the Press On Fund. Each necklace features: a bright heart built from tiny bricks—a playful nod to Patrick, who always carried mini-figures in his pocket, and a “PRESS…

Press On recently committed $500,000 to continue funding The Leukemia & Lymphoma Society (LLS) Dare to Dream Project, including the first-ever Pediatric Acute Leukemia Master Clinical Trial (PedAL) to accelerate safer, less toxic, and more effective treatments for kids. PedAL is the first integrated, global, acute leukemia master clinical trial to test new, safer therapies…

Press On is proud to continue its support of the Children’s Hospital of Georgia’s Pediatric Immunotherapy Program (PIP) founded by Dr’s. Ted Johnson and David Munn. PIP provides highly specialized experimental immunotherapy treatments for some of the hardest to treat childhood cancers, actively reshaping survival odds and treatment opportunities for children from around the country…

Although the pediatric cancer landscape has changed dramatically for certain cancers in the past decade, children with certain diagnoses still face dismal survival rates and treatment options. You’re changing the script at the Children’s Hospital of Georgia, where the Pediatric Immunotherapy Program (PIP) founded by Drs. Ted Johnson and David Munn provides highly-specialized experimental immunotherapy…

The Press On Fund Collaborates with the Leukemia & Lymphoma Society (LLS) by granting $100,000 to Dr. Soheil Meshinchi’s Specialized Center of Research Grant. Immunotherapeutic Targeting of AML Targets in Infants and Children Pediatric acute myeloid leukemia (AML) is among the most lethal cancers in children, with an overall mortality rate of 60 percent from…

It is sometimes hard for me to believe that Hallie has been fighting her on again, off again battle with cancer for twelve years. Somehow she’s pressed on through three brain tumor diagnoses, multiple rounds of brain and spine radiation, and months of chemotherapy. Not to mention three port placements, two port removals, one long…

Thanks to your generosity, we’re enabling hundreds of thousands of dollars in research all over the world to create less toxic and more effective therapies to treat childhood cancer. In 2019, PRESS ON made a 4-year, $1 million pledge to the Children’s Hospital of Georgia (CHOG). The first $500,000 of that pledge, granted out and…

In 2017, Press On Fund combined forces with Target Pediatric AML (TpAML), a grass roots collaborative funding initiative led by fellow AML parent, Julie Guillot, and others to identify, fund, and accelerate the #1 priority research project for AML patients ages 0-35. TpAML was endorsed by the Children’s Oncology Group as the “highest potential, greatest…